Hired to grow market share, strengthen account relationships, and lead educational programs for Entereg (alvimopan) within Omaha-Lincoln, NE; Des Moines, IA; and Yankton-Sioux Falls, SD geography. Call on key medical personnel, including Colorectal, General, and Oncologic Surgeons; Pharmacy staff; Pre-op, Post-op, PACU nursing staff; and surgery residents throughout Hospitals and Office Based accounts.Communicate the value of Entereg as a perioperative option to speed GI recovery in bowel resection patients. Update Surgery Standing order sets with the addition of Entereg, and present pharmaco-economic data to members of the Pharmacy & Therapeutic Committee in order to gain formulary approval.Drove product pull-through at key teaching institutions, including the University of Nebraska Medical Center, Creighton University, and Mercy Medical Center. Secured a formulary review and clinical trial at a Tier 5 hospital within 2 months out of training. Utilized clinical knowledge and influencing skills to motivate action for the addition of Entereg to the standing bowel resection order sets of 5 high potential, Private, General Surgery groups.

Positioned and launched a new atypical antipsychotic product in NE, IA, and SD. Gained sales traction with hospitals and state behavioral health centers despite significant generic and branded competition, and minimal healthcare coverage for mental health. Hosted multiple speaker programs featuring key Local, Regional, and National Opinion Leaders to educate target Physicians, Staff, & Pharmacy of Territory Hospitals, and State Behavioral Health Centers; address patient care issues; and build product awareness.Won formulary approval and grew sales with top 5 high potential accounts - Douglas County Community Mental Health Center, South Dakota Human Services Center, Lincoln Regional Center, and the Department of Human Services (DHS), Glenwood Resource Center. Ranked #8 out of 24 territories, earning an Award for Excellence.

Sold 3 late-cycle products into hospital specialty areas, including Anesthesiology, Cardiology, and Infectious Disease, covering the OR, ER, cath labs, coronary care units (CCU), and intensive care units (ICU). Established business relationships with anesthesiologists, ER physicians, interventional cardiologists, and nurse anesthetists, among other key staff. Increased adoption and utilization of Zemuron (IV neuromuscular blocking agent for general surgery), Integrilin (IV anti-platelet inhibitor used during percutaneous intervention) and Avelox (IV anti-infective), despite increasing threat from generic competition. Generated anesthesia sales in the top 25% for 2007. Recognized with a promotion to Senior Specialty Hospital Sales Representative, Neuropsychiatry Division.

Led territory sales for the Anesthesia product portfolio, covering Zemuron (IV neuromuscular blocking agent), Anzement (post operative nausea and vomiting / PONV product), and Azinza (once-daily formulation of morphine). Cultivated relationships with anesthesiologists, pain specialists, and nurse anesthetists at all levels of seniority, including residents, Directors, and the #1 pain specialist in the territory. Built a relationship with Creighton University Medical Center, a small teaching institution, which led to a Phase IIIa safety trial for an experimental reversal agent not yet FDA approved. Increased account usage of complementary product Zemuron. Re-introduced a new 10ML vial formulation of Zemuron to several teaching institutions, which increased product awareness and utilization. Qualified for several of the company’s most elite honors, including Regional Territory Manager of the Year and Top 10% Club.

Generated sales for the entire product portfolio, managing relationships with Family / Internal Medicine, Pain Specialists, and OB/GYN physicians. Grew market share of NuvaRing (alternative contraceptive) throughout OB/GYN Specialty accounts, and launched Avinza (once daily morphine) to Pain Specialists, resulting in top 10% market share within a 10-state region for both products. 1st place Winner of Power of Two Contest and Regional Representative High Achiever, Primary Healthcare Team in 2004.

Led the launch and growth of an antithrombotic product into key hospital accounts within Omaha/ Lincoln, NE, and Sioux Falls, SD territory. Employed relationship selling strategies to win formulary approval and promote adoption with orthopedic surgeons, pulmonologists, and hematologists. Bolstered formulary approval 50%, ranked in the top 10% for regional sales, and earned recognition as a Go for the Gold contest winner.

Excelled as a new Specialty Representative with focus in Anesthesia and Psychiatry, promoting Zemuron, Raplon, Remeron, and Tice BCG to anesthesiologists, nurse anesthetists, psychiatrists, and urologists in Omaha, NE and Western IA. Ranked #2 for antidepressant sales in a 9-state Midwest region and #9 on a national level. Achieved #1 market share rank in the nation during 1st and 2nd quarter of product launch for new Anesthesia drug. Won Regional Representative High Achiever award in 2001. Nominated for a Rising Star Award in 2000. Awarded a 2001 promotion to Hospital Sales Specialist, Antithrombotic Division.